• 1
    Russian Federal Service of State Statistics. Healthcare in Russia [Russian]. 2011. Russia:; Yaroslavl: Accessed March 18, 2013.
  • 2
    Oganov RG, Timofeeva TN, Koltunov IE, et al. Arterial hypertension epidemiology in Russia; the results of 2003–2010 federal monitoring. Cardiovasc Ther Prev. 2011;10:913.
  • 3
    The Health and Social Care Information Centre. Hypertension. In: Health Survey for England 2011: Health, Social Care and Lifestyles: Summary of Key Findings. Leeds, UK: The Health and Social Care Information Centre; 2012:134.
  • 4
    Yoon SS, Burt V, Louis T, Carroll MD. Hypertension Among Adults in the United States, 2009–2010. NCHS data brief, no 107. Hyattsville, MD: National Center for Health Statistics. 2012.
  • 5
    Godet-Mardirossian H, Girerd X, Vernay M, et al. Patterns of hypertension management in France (ENNS 2006–2007). Eur J Prev Cardiol. 2012;19:213220.
  • 6
    Wilkins K, Campbell NRC, Joffres MR, et al. Blood pressure in Canadian adults. Health Rep. 2010;21:3746.
  • 7
    Joffres MR, Hamet P, MacLean DR, et al. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001;14(11 Pt 1):10991105.
  • 8
    Campbell NR, Chen G. Canadian efforts to prevent and control hypertension. Can J Cardiol. 2010;26(Suppl C):14C17C.
  • 9
    Campbell NR, Brant R, Johansen H, et al. For the Canadian Hypertension Education Program Outcomes Research Task Force. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009;53:128134.
  • 10
    Mozheyko M, Eregin S, Vigdorchik A, et al. A cross-sectional survey of hypertension diagnosis and treatment practices among primary care physicians and cardiologists of Yaroslavl Region in Russia. Adv Ther. 2012;29:10161025.
  • 11
    Chazova IE, Ratova LG, Boytsov SA, et al. For the Experts Committee, Russian Medical Society of Hypertension and Russian Scientific Society of Cardiology. Diagnostics and treatment of arterial hypertension. Russian Guidelines (4th review): Systemic Hypertension. 2010;3:526.
  • 12
    Gee ME, Campbell NR, Gwadry-Sridhar F, et al. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol. 2012;28:383389.
  • 13
    Friedman O, McAlister FA, Yun L, et al. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med. 2010;123:173181.
  • 14
    Yiannakopoulou E, Papadopulos J, Cokkinos D, et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12:243249.
  • 15
    Sokol M, McGuigan K, Verbrugge R, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521530.
  • 16
    Breekveldt-Postma N, Penningvan-Beest FJA, Siiskonen SJ, et al. Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin. 2008;24:10251031.
  • 17
    Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich). 2009;11:376382.
  • 18
    World Health Organization Executive Board. Draft action plan for the prevention and control of noncommunicable diseases 2013–2020. 11 January 2013. Accessed August 19, 2013.
  • 19
    Chalmers J, Arima H, Harrap S, et al. Global survey of current practice in management of hypertension as reported by societies affiliated with the International Society of Hypertension. J Hypertens. 2013;31:10431048.
  • 20
    Moser M. Hypertension treatment–a success story. J Clin Hypertens (Greenwich). 2006;8:313314.
  • 21
    Shkolnikov V, Meslé F, Leon DA. Premature cardiovascular mortality in Russia in the light of population- and individual-level evidence. In: Weidner G, Kopp SM, Kristenson M, eds. Heart Disease: Environment, Stress and Gender. Nato Science Series, Series I: Life and Behavioural Sciences, vol. 327. Amsterdam: NATO; 2001:3968.
  • 22
    Shkolnikov VM, Andreev EM, Leon DA, et al. Mortality reversal in Russia: the story so far. Hygiea Internationalis. 2004;4:2980.
  • 23
    Roberts B, Stickley A, Balabanova D, et al. Irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2010;66:482488.
  • 24
    Roberts B, Stickley A, Balabanova D, et al. The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012;66:10791082.
  • 25
    Grassi G, Cifkova R, Laurent S, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J. 2011;32:218225.
  • 26
    Rechel B, Roberts B, Richardson E, et al. Health and health systems in the Commonwealth of Independent States. Lancet. 2013;381:11451155.
  • 27
    Greenberg HM, Galyavich AS, Ziganshina LE, et al. Identification and management of patients with hypertension in the polyclinic system of the Russian Federation. Am J Hypertens. 2005;18:943948.
  • 28
    Cutler JA, Sorlie P, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in the United States between 1988–2004 and 1999–2004. Hypertension. 2008;52:818827.
  • 29
    Cifkova R, Skodova Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010;211:676681.
  • 30
    Jaffe MG, Young JD. The Permanente Medical Group. The Kaiser Permanente Northern California Hypertension Project 2001–2009: how an integrated care delivery system increased blood pressure control rates from 44% to 80% in 8 years. [abstract OR-13.]. J Clin Hypertens (Greenwich). 2011;13(Suppl 1):A6.